Femme et Homme
- | Pays :
- Canada
- France
- United States
- | Organes : -
- | Spécialités : -
Extrait
This is a Phase I/II, ascending, multi-dose study of BMS-663513, an agonistic anti-CD137 monoclonal antibody, administered every three weeks to patients with metastatic or locally advanced solid tumors.
Critère d'inclusion
- Tumors